salesforce.com (CRM) Reiterated at Overweight by Cantor Fitzgerald - 'BRZE Acquisition a Positive Capalyst'

Cantor Fitzgerald analyst Matthew VanVliet reiterated an Overweight rating and $300.00 price target on salesforce.com (NYSE: CRM).

The analyst commented, "We reiterate our OW rating on CRM shares, as we view the acquisition of BRZE as a positive catalyst for CRM growth, further margin leverage, and long-term FCF generation. This helps jump start the revival of Marketing Cloud and adds more value to the entire CRM ecosystem, in our opinion, at a reasonable acquisition price, fully funded by current FCF generation."

For an analyst ratings summary and ratings history on salesforce.com click here. For more ratings news on salesforce.com click here.

Shares of salesforce.com closed at $242.43 yesterday.

You May Also Be Interested In

• Salesforce grants RSUs to m3ter and Fin employees after acquisitions
• Summit Therapeutics and Lunit partner on AI pathology for cancer research
• Zefiro Methane closes C$5M non-brokered private placement